What Can We Expect from Value-Based Funding of Medicines? A Retrospective Study

@article{Harris2015WhatCW,
  title={What Can We Expect from Value-Based Funding of Medicines? A Retrospective Study},
  author={Anthony Harris and Juan Li and Karen Yong},
  journal={PharmacoEconomics},
  year={2015},
  volume={34},
  pages={393-402}
}
Deciding on public funding for pharmaceuticals on the basis of value for money is now widespread. We suggest that evidence-based assessment of value has restricted the availability of medicines in Australia in a way that reflects the relative bargaining power of government and the pharmaceutical industry. We propose a simple informal game-theoretic model of bargaining between the funding agency and industry and test its predictions using a logistic multiple regression model of past funding… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 11 times over the past 90 days. VIEW TWEETS
2 Citations
22 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 22 references

2013

  • OECD Health Dat
  • http://stats.oecd.org/Index.aspx? DataSetCode=SHA…
  • 2013
1 Excerpt

Similar Papers

Loading similar papers…